MedTrace Logo

Vitamin A and Azithromycin for Acne Vulgaris

NCT03090048 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-02-25

No results posted yet for this study

Summary

Patients seen with acne lesions not having responded to existing treatments will be offered a placebo or a topical preparation consisting of Vitamin A USP with or without Azithromycin for a duration of 4-6 months USP for the objective of resolving the lesions without systemic side effects and via weekly follow-ups.

Conditions

  • Acne Vulgaris

Interventions

DRUG

Vitamin A

Vitamin A 2-3 % concentration

DRUG

Azithromycin

azithromycin monohydrate

Sponsors & Collaborators

  • Manchanda Medical Clinic

    lead OTHER

Principal Investigators

  • Vinod C Tawar · M.D.

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2021-08-24
Completion
2021-10-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03090048 on ClinicalTrials.gov